Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?

Lancet. 2003 Aug 16;362(9383):504-5. doi: 10.1016/S0140-6736(03)14149-9.

Authors

Gordon D O Lowe¹, Peter A G Sandercock, Frits R Rosendaal

Affiliation

¹ University Department of Medicine, Royal Infirmary, Glasgow G31 2ER, UK. gdl1j@clinmed.gla.ac.uk

PMID: 12932379
DOI: 10.1016/S0140-6736(03)14149-9

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Anticoagulants / therapeutic use*
Arthroplasty, Replacement
Clinical Trials as Topic / standards
Fondaparinux
Humans
Orthopedic Procedures*
Osteoarthritis, Hip / surgery
Osteoarthritis, Knee / surgery
Polysaccharides / therapeutic use*
Postoperative Complications / prevention & control*
Research Design / standards
Thromboembolism / prevention & control*
Treatment Outcome
Venous Thrombosis / prevention & control*

Substances

Anticoagulants
Polysaccharides
Fondaparinux